Clinical Trials on Diabetes Melliuts, Type 2

Total 18502 results

Daewoong Pharmaceutical Co. LTD.

Unknown

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
ConjuChem

Terminated

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

United States, Canada
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

Type 2 Diabetes Mellitus (T2DM)
Ligand Pharmaceuticals
Medpace, Inc.

Completed

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Type 2 Diabetes Mellitus (T2DM)

United States
Merck Sharp & Dohme LLC
Pfizer

Completed

A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038)

Type 2 Diabetes Mellitus (T2DM)
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

United States
Institut National de la Santé Et de la Recherche...

Recruiting

CARdiomyopathy in Type 2 DIAbetes Mellitus (CARDIATEAM)

Cardiomyopathy, Diabetic

France, Germany, Spain, Netherlands, United Kingdom
Istanbul University

Completed

The Effects of Short Message Notifications on Middle-Aged Diabetic Patients

Type2 Diabetes Mellitus
New York Institute of Technology
American Osteopathic Association

Recruiting

Diabetes and Osteopathic Manipulative Medicine (OMM)

Type2 Diabetes Mellitus | Osteopathy in Diseases Classified Elsewhere

United States
AstraZeneca

Recruiting

Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)

China
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)
Zhongda Hospital

Recruiting

Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China
Newsoara Biopharma Co., Ltd.

Recruiting

Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

T2DM (Type 2 Diabetes Mellitus)

China
Shanghai Golden Leaf MedTec Co. Ltd

Active, not recruiting

Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China
Sanofi

Completed

A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India (PERSISTENT)

Type 2 Diabetes Mellitus (T2DM)

France
Haisco Pharmaceutical Group Co., Ltd.

Completed

Single Escalating Dose Study Of HSK7653 In Healthy Subjects

T2DM (Type 2 Diabetes Mellitus)

China
PegBio Co., Ltd.

Completed

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects (PB119)

Type 2 Diabetes Mellitus (T2DM)

China
Oramed, Ltd.
Integrium

Terminated

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Daewoong Pharmaceutical Co. LTD.

Completed

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
AJU Pharm Co., Ltd.

Completed

The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)
AJU Pharm Co., Ltd.

Completed

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Diabetes type2

Korea, Republic of
National University of Singapore

Completed

Collaborative Care Model on Type 2 Diabetic Patients

Type2 Diabetes

Singapore
Weill Cornell Medical College in Qatar
Novo Nordisk A/S

Terminated

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Type2 Diabetes

Qatar
Hospices Civils de Lyon

Completed

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes (COMPLETE)

Type2 Diabetes

France
Nanjing First Hospital, Nanjing Medical University

Unknown

Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

China
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics (CGM_IRB2)

Type2 Diabetes

United States
VitNovo, Inc.

Completed

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Taiwan
Qianfoshan Hospital

Completed

Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy

Type2 Diabetes

China
Insulet Corporation
Jaeb Center for Health Research

Completed

OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D)

Type2 Diabetes

United States
Clinical Research Centre, Malaysia
Ministry of Health, Malaysia

Completed

Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education (EPICCIHKDMEP)

Diabetes Mellitus | Type2 Diabetes

Malaysia
Chungbuk National University Hospital

Completed

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
ValoTec
APHP

Terminated

Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

France
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
National Taipei University of Nursing and Health...
Chiayi Christian Hospital

Completed

Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients (ISTE)

Type2 Diabetes
Istanbul Medeniyet University

Completed

The Effect of Fasting on Serum Osmolarity in Diabetic Patients

Type2 Diabetes

Turkey
Arizona State University

Completed

An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients

Type2 Diabetes
Zhejiang Provincial People's Hospital

Not yet recruiting

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Type2 Diabetes | type1diabetes

China
Yanbing Li

Recruiting

Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification (ESTIMATOR)

Diabetes type2

China
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Recruiting

Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Type2 Diabetes

France
Penn State University

Completed

Almond Butter and Fasting Glucose

Type2 Diabetes

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
Faculty of Medical Sciences, Clinical Hospital

Completed

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Type2 Diabetes

Spain
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) (CGM_IRB-3)

Type2 Diabetes

United States
Tel-Aviv Sourasky Medical Center

Unknown

16-week Flexible vs. 8-week Semaglutide Titration

Diabetes type2

Israel
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Completed

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

Type2 Diabetes

France
Centro de Estudios en Alimentación y Nutrición,...

Completed

Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics

Type2 Diabetes

Chile

3

Subscribe